1. Predictive value of plasma copeptin level for diagnosis and mortality of pulmonary embolism
- Author
-
Onur Sinan Deveci, Ali Deniz, Caglar Emre Cagliyan, Ismail Hanta, Ayhan Usal, Muhammet Bugra Karaaslan, Oya Baydar, Caglar Ozmen, and Anil Akray
- Subjects
medicine.medical_specialty ,Medicine (General) ,Embolia pulmonar/diagnóstico ,Hemodynamics ,Arginine vasopressin/metabolism ,030204 cardiovascular system & hematology ,03 medical and health sciences ,Plasma ,0302 clinical medicine ,Copeptin ,R5-920 ,Disease severity ,Predictive Value of Tests ,Internal medicine ,medicine ,Humans ,030212 general & internal medicine ,Arginina vasopressina/metabolism ,business.industry ,Morte ,Glycopeptides ,Copeptin Measurement ,General Medicine ,medicine.disease ,Prognosis ,Predictive value ,Pulmonary embolism ,Death ,Biomarcadores ,Predictive value of tests ,Acute Disease ,Cardiology ,Biomarker (medicine) ,Embolia pulmonar/mortalidade ,Pulmonary embolism/mortality ,business ,Pulmonary Embolism ,Biomarkers ,Pulmonary embolism/diagnosis - Abstract
SUMMARY OBJECTIVE: Early diagnosis and risk stratification may provide a better prognosis in pulmonary embolism (PE). Copeptin has emerged as a valuable predictive biomarker in various cardiovascular diseases. The aim of this study was to determine the levels of copeptin in patients with acute PE and to evaluate its relationship with disease severity and PE-related death. METHODS: Fifty-four patients and 60 healthy individuals were included in this study. Copeptin concentrations and right ventricular dysfunction were analyzed. The correlation between copeptin levels and hemodynamic and echocardiographic parameters was examined. After these first measurements, patients were evaluated with PE-related mortality at the one-year follow-up. RESULTS: The copeptin levels were higher in PE patients than in the control group (8.3 ng/mL vs 3.8 ng/mL, p
- Published
- 2020